sab-176
Generic: human polyclonal IgG
sab-176: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| SAB BIOTHERAPEUTICS, INC. (SABS) | Phase 2 |
Get deeper analysis on sab-176
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis